Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome
- 1 June 2000
- journal article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 15 (6), 1266-1274
- https://doi.org/10.1093/humrep/15.6.1266
Abstract
To study the contributions of body mass, body fat distribution and family history of type 2 diabetes mellitus to hyperinsulinaemia, insulin secretion and resistance in polycystic ovarian syndrome (PCOS), 17 lean (LC) and 17 obese (OC) healthy control subjects, and 15 lean (LPCOS) and 28 obese (OPCOS) women with PCOS were investigated. Waist:hip ratio (WHR), serum concentrations of sex steroids, glucose and insulin during a 75 g oral glucose tolerance test (OGTT), and insulin and C-peptide early phase secretion, and insulin sensitivity index using a euglycaemic hyperinsulinaemic clamp were assessed. The PCOS subjects had a higher mean WHR than the controls. A trend towards hyperinsulinaemia and impairment of insulin sensitivity (including the rates of both glucose oxidation and non-oxidation) was observed in LPCOS subjects, but only in OPCOS subjects were these changes significant. Early phase insulin secretion but not the early phase C-peptide secretion was increased in PCOS subjects compared to controls, suggesting that peripheral hyperinsulinaemia in PCOS women was mainly due to the observed lowered hepatic insulin extraction and insulin resistance in skeletal muscle. Moreover, the presence of a family history of type 2 diabetes did not affect early phase insulin or C-peptide secretion in the PCOS group. These results confirm and strengthen earlier contentions, that insulin resistance is a characteristic defect in PCOS and is worsened particularly by abdominal obesity.Keywords
This publication has 49 references indexed in Scilit:
- Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disordersFertility and Sterility, 1999
- Body fat distribution, insulin resistance, and metabolic diseasesNutrition, 1997
- Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndromeHuman Reproduction, 1997
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 1997
- Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow upBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Body Composition and Regional Fat Distribution in Polycystic Ovarian Syndrome Relationship to Hormonal and Metabolic ProfilesAnnals of the New York Academy of Sciences, 1993
- Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of womenActa Obstetricia et Gynecologica Scandinavica, 1992
- Impact of Obesity on Insulin Action in Volunteers with Normal Glucose Tolerance: Demonstration of a Threshold for the Adverse Effect of Obesity*Journal of Clinical Endocrinology & Metabolism, 1990
- Influence of Changes in Insulin Receptor Binding during Insulin Infusions on the Shape of the Insulin Dose-Response Curve for Glucose Disposal in Man*Journal of Clinical Endocrinology & Metabolism, 1984
- Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease*Journal of Clinical Endocrinology & Metabolism, 1983